Fuan Pharmaceutical Group Co (300194) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.27 Million ≈ $14.67 Million USD) by net assets (CN¥4.45 Billion ≈ $651.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Fuan Pharmaceutical Group Co for the company's overall valuation and market capitalisation.
Fuan Pharmaceutical Group Co - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Fuan Pharmaceutical Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Fuan Pharmaceutical Group Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fuan Pharmaceutical Group Co ranked by their cash flow conversion efficiency. Explore Fuan Pharmaceutical Group Co (300194) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DBAPPSecurity Co Ltd
SHG:688023
|
0.004x |
|
Qian Jiang Water Resources Development Co Ltd
SHG:600283
|
0.031x |
|
Zhejiang Xinao Textiles Inc
SHG:603889
|
0.064x |
|
Sawit Sumbermas Sarana Tbk
JK:SSMS
|
-0.225x |
|
Kodiak AI, Inc. Common Stock
NASDAQ:KDK
|
-0.996x |
|
SimilarWeb Ltd
NYSE:SMWB
|
0.012x |
|
Cubic Sensor and Instrument Co Ltd
SHG:688665
|
0.039x |
|
Shenzhen Easttop Supply Chain Management Co Ltd
SHE:002889
|
-0.095x |
Annual Cash Flow Conversion Efficiency for Fuan Pharmaceutical Group Co (2007–2025)
The table below shows the annual cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2025. View 300194 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.37 Billion ≈ $638.81 Million |
CN¥312.32 Million ≈ $45.70 Million |
0.072x | +3.65% |
| 2024-12-31 | CN¥4.40 Billion ≈ $643.58 Million |
CN¥303.59 Million ≈ $44.42 Million |
0.069x | -12.95% |
| 2023-12-31 | CN¥4.15 Billion ≈ $607.09 Million |
CN¥328.98 Million ≈ $48.14 Million |
0.079x | -7.82% |
| 2022-12-31 | CN¥3.95 Billion ≈ $577.49 Million |
CN¥339.50 Million ≈ $49.68 Million |
0.086x | +29.34% |
| 2021-12-31 | CN¥3.87 Billion ≈ $565.70 Million |
CN¥257.13 Million ≈ $37.63 Million |
0.067x | +86.38% |
| 2020-12-31 | CN¥4.56 Billion ≈ $666.55 Million |
CN¥162.55 Million ≈ $23.79 Million |
0.036x | -51.84% |
| 2019-12-31 | CN¥3.99 Billion ≈ $583.77 Million |
CN¥295.63 Million ≈ $43.26 Million |
0.074x | +2.27% |
| 2018-12-31 | CN¥3.69 Billion ≈ $540.55 Million |
CN¥267.68 Million ≈ $39.17 Million |
0.072x | -33.34% |
| 2017-12-31 | CN¥4.17 Billion ≈ $610.29 Million |
CN¥453.37 Million ≈ $66.34 Million |
0.109x | +15.16% |
| 2016-12-31 | CN¥3.96 Billion ≈ $580.00 Million |
CN¥374.16 Million ≈ $54.75 Million |
0.094x | +25.23% |
| 2015-12-31 | CN¥2.14 Billion ≈ $312.59 Million |
CN¥161.03 Million ≈ $23.56 Million |
0.075x | +511.64% |
| 2014-12-31 | CN¥1.71 Billion ≈ $249.86 Million |
CN¥-31.27 Million ≈ $-4.58 Million |
-0.018x | -135.25% |
| 2013-12-31 | CN¥1.72 Billion ≈ $252.41 Million |
CN¥89.61 Million ≈ $13.11 Million |
0.052x | +42.41% |
| 2012-12-31 | CN¥1.72 Billion ≈ $251.77 Million |
CN¥62.77 Million ≈ $9.18 Million |
0.036x | -4.80% |
| 2011-12-31 | CN¥1.69 Billion ≈ $247.66 Million |
CN¥64.85 Million ≈ $9.49 Million |
0.038x | -89.82% |
| 2010-12-31 | CN¥281.05 Million ≈ $41.13 Million |
CN¥105.74 Million ≈ $15.47 Million |
0.376x | -2.08% |
| 2009-12-31 | CN¥163.31 Million ≈ $23.90 Million |
CN¥62.75 Million ≈ $9.18 Million |
0.384x | -13.55% |
| 2008-12-31 | CN¥110.76 Million ≈ $16.21 Million |
CN¥49.23 Million ≈ $7.20 Million |
0.444x | -80.47% |
| 2007-12-31 | CN¥8.31 Million ≈ $1.22 Million |
CN¥18.92 Million ≈ $2.77 Million |
2.276x | -- |
About Fuan Pharmaceutical Group Co
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) … Read more